AIM ImmunoTech to Discuss First Quarter 2023 Financial Results on May 16, 2023 and Host Conference Call and Webcast

OCALA, Fla., May 09, 2023 -- AIM ImmunoTech Inc.  , an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and... | May 9, 2023

Related Keywords

United States ,American ,Thomask Equels ,Christopher Mcaleer ,Jenene Thomas ,Immunotech Inc ,Facebook ,Twitter ,Linkedin ,Chief Executive Officer ,Tech Conference ,Aim Immunotech Inc Stock Exchange ,News ,Information ,Press Release ,Bay ,023 ,Rim ,Immunotech ,N ,Company ,Ocused ,The ,Research ,End ,Development ,F ,Herapeutics ,O ,Treat ,Multiple ,Types ,Mmune Aim Us00901b1052 ,